Cincinnati Public Radio: Researchers Zeroing In On Blood Vessels to Prevent COVID 'Long-Haulers'

UC physicians discuss clinical trial designed to help COVID patients

Richard Becker, MD, and Duncan Hite, MD, both professors in the UC College of Medicine and UC Health physicians, spoke with WVXU reporter Ann Thompson about a phase 2 clinical trial underway at UC/UC Health to determine the safety and efficacy of the drug razuprotafib in treating COVID-19 patients. UC is one of 20 sites across the nation participating in the trial.

Researchers say this drug could possibly prevent "long-haulers syndrome." Razuprotafib is already used to treat diabetes and renal disease. By zeroing in on blood vessels to make them healthier, it's hoped COVID patients can benefit, too. Becker, director of the UC Heart, Lung and Vascular Institute, and Hite, director of medical critical care at UC Health, are part of a clinical trial conducted by Aerpio Pharmaceuticals.

Listen to the interview online.

Learn more about the clinical trial on UC’s website.

Next Lives Here

The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.

Related Stories

1

Cincinnati sees record rainfall in weekend deluge

July 21, 2026

The Cincinnati Enquirer talks to UC College of Engineering and Applied Science Associate Professor Patrick Ray for context about a July 17 rainstorm that dumped a record amount of rain on parts of Cincinnati.

2

Putting preschool into perspective

July 20, 2026

Preschool and childcare can be difficult to navigate for parents, as Spectrum News 1 Ohio recently reported. Waitlists are long, and factors like cost, location and transportation can limit options. According to a recent study published by The Annie E. Casey Foundation, only 41% of 3- to 4-year-olds in Ohio were enrolled in preschool between 2020 and 2024 — a 4% decrease from pre-pandemic numbers. For University of Cincinnati early childhood education faculty member Chad Nunamaker, that statistic has caveats.

3

Ticks that survive pesticides can withstand colder winters

July 17, 2026

Ticks that survive less-than-lethal doses of pesticide are able to withstand dangerous cold, which could help them expand their range farther north, according to researchers at the University of Cincinnati and the U.S. Department of Agriculture.